Expression of matrix metalloproteinases by human plasma cells and B lymphocytes

European Journal of Immunology

Volumn 28, Issue 6, 1998, Pages 1773-1784

  Di Girolamo, Nick ^a   Tedla, Nicodemus ^a   Lloyd, Andrew ^a   Wakefield, Denis ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

B lymphocyte; Inflammation; Rheumatoid arthritis; Scleritis

Indexed keywords

CASEIN; CYTOKINE; GELATIN; GELATINASE B; IMMUNOGLOBULIN G; MESSENGER RNA; METALLOPROTEINASE; PROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; B LYMPHOCYTE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY DISEASE; NORTHERN BLOTTING; PLASMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SCLERITIS;

ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; COLLAGENASES; HUMANS; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MONENSIN; PLASMA CELLS; RNA, MESSENGER; SCLERITIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031868017     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199806)28:06<1773::AID-IMMU1773>3.0.CO;2-B     Document Type: Article

References (41)

1. Clark, E. A. and Lane, P. J. L., Regulation of human B-cell activation and adhesion. Annu. Rev. Immunol. 1991. 9: 97-127.
2. + T cells or their membranes. Blood. 1993. 82: 2781-2789.
3. Andrew, E. M., Plater-Zyberk, C., Brown, C. M. S., Williams, D. G. and Maini, R. N., The potential role of B-lymphocytes in the pathogenesis of rheumatoid arthritis. Br. J. Rheumatol. 1991. 30 (Suppl 1): 47-52.
4. Bernauer, W., Watson, P. G., Daicker, B. and Lightman, S., Cells perpetuating the inflammatory response in scleritis. Br. J. Ophthalmol. 1994. 78: 381-385.
5. Brown, K. A., Perry, M. E., Mustafa, Y., Wood, S. K., Crawely, M., Taub, N. and Dumonde, D. C., The distribution and abnormal morphology of plasma cells in rheumatoid synovium. Scand. J. Immunol. 1995. 41: 509-517.
6. Matthews, J. B., Deacon, E. M., Wilson, C., Potts, A. J. C. and Hamburger, J., Plasma cell populations in labial salivary glands from patients with and without Sjogren's syndrome. Histopathology 1993. 23: 399-407.
7. Ito, A., Hirota, S., Mizuno, H., Kawasaki, Y., Takemura, T., Nishiura, T., Kanakura, Y., Katayama, Y., Nomura, S. and Kitamura, Y., Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: possible involvement in the development of edema in chronic inflammation. Pathol. Int. 1995. 45: 715-720.
8. 1. Eur. J. Immunol. 1995. 25: 508-512.
9. Di Girolamo, N., Visvanathan, K., Lloyd, A. and Wakefield, D., Expression of TNF-α by human plasma cells in chronic inflammation. J. Leukoc. Biol. 1997. 61: 667-678.
10. Stetler-Stevenson, W. G., Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am. J. Pathol. 1996. 148: 1345-1350.
11. Puente, X. S., Pendas, M. A., Llano, E., Velasco, G. and Lopez-Otin, C., Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer. Res. 1996. 56: 944-949.
12. Kinoshita, T., Sato, H., Takino, T., Itoh, M., Akizawa, T. and Seiki, M., Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase. Cancer Res. 1996. 56: 2535-2538.
13. Di Girolamo, N., Lloyd, A., McCluskey, P. J., Filipic, M. and Wakefield, D., Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am. J. Pathol. 1997. 105: 653-666.
14. MacNaul, K. I., Chartrain, N., Lark, M., Tocci, M. J. and Hutchinson, N. I., Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinase-1 in rheumatoid human synovial fibroblasts. J. Biol. Chem. 1990. 265: 17238-17245.
15. Lees, M., Taylor, D. J. and Woolley, D. E., Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur. J. Biochem. 1994. 223: 171-177.
16. Suzuki, K., Enghild, J. J., Morodomi, T., Salvesen, G. and Nagase, H., Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 1990. 29: 10261-10270.
17. DeClerck, Y. A., Yean, T.-D. Lu, H. S., Ting, T. and Langley, K. E., Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J. Biol. Chem. 1991. 266: 3893-3899.
18. Salo, T., Makela, M., Kylmaniemi, M., Autio-Harmainen, H. and Larjava, H., Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab. Invest. 1994. 70: 176-182.
19. Rodgers, W. H., Matrisian, L. M., Giudice, L. C., Dsupin, B., Cannon, P., Svitek, C., Gorstein, F. and Osteen, K. G., Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J. Clin. Invest. 1994. 94: 946-953.
20. McCachren, S. S., Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum. 1991. 34: 1085-1093.
21. Onisto, M., Riccio, M. P., Scannapieco, P., Caenazzo, C., Griggio, L., Spina, M., Stetler-Stevenson, W. G. and Garbisa, S., Gelatinase A/TIMP-2 imbalance in lymph-node-positive breast carcinomas, as measured by RT-PCR. Int. J. Cancer. 1995. 63: 621-626.
22. Di Girolamo, N., McCluskey, P. J., Lloyd, A. and Wakefield, D., Stromelysin (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase (TIMP-1) mRNA expression in scleritis. Ocular. Immunol. Inflamm. 1995. 3: 181-194.
23. Huhtala, P., Chow, L. T. and Tryggvason, K., Structure of the human type IV collagenase gene. J. Biol. Chem. 1990. 265: 11077-11082.
24. Ahemed, A. A., Nordlind, K., Schultzberg, M. and Linden, S., Interleukin-1 alpha-and beta-, interleukin-6-and tumour necrosis factor-alpha-like immunoreactivities in chronic granulomatous skin conditions. Acta Derm. Venereol. 1994. 74: 435-440.
25. Kubota, S., Fridman, R. and Yamada, Y., Transforming growth factor-β suppresses the invasiveness of human fibrosarcoma cells in vitro by increasing expression of tissue inhibitor of metalloproteinase. Biochem. Biophys. Res. Commun. 1991. 176: 129-136.
26. Unemori, E. N., Ferrara, N., Bauer, E. A. and Amento, E. P., Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. Cell. Physiol. 1992. 153: 557-562.
27. Leppert, D., Hauser, S. L., Kishiyama, J. L., An, S., Zeng, L. and Goetzl, E. J., Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids. FASEB J. 1995. 9: 1473-1481.
28. Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K. A., Gerhart, M., Davis, R., Fitzner, J. N., Johnson, R. S., Paxton, R. J., March, C. L. and Cerretti, D. P., A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 1997. 385: 729-733.
29. Shipley, J. M., Doyle, G. A. R., Fliszar, C. J., Ye, Q.-Z., Johnson, L. L., Shapiro, S. D., Welgus, H. G. and Senior, R. M., The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. J. Biol. Chem. 1996. 271: 4335-4341.
30. Okada, Y., Gonoji, Y., Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K. and Taro, T., Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. J. Biol. Chem. 1992. 267: 21712-21719.
31. Quantin, B., Murphy, G. and Breathnach, R., Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry. 1989. 28: 5327-5334.
32. McKie, N., Dallas, D. J., Edwards, T., Apperley, J. F., Graham, R., Russell, G. and Croucher, P. I., Cloning of a novel membrane-linked metalloproteinase from human myeloma cells. Biochem. J. 1996. 318: 459-462.
33. Dean, D. D., Martel-Pelletier, J., Pelletier, J.-P., Howell, D. S. and Woessener, J. F. Jr., Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritis cartilage. J. Clin. Invest. 1989. 84: 678-685.
34. Konttinen, Y. T., Lindy, O., Kemppinen, P., Saari, H., Soumalainen, K., Vauhkonen, M., Lindy, S. and Sorsa, T., Collagenase reserves in polymorphonuclear neutrophil leukocytes from patients with rheumatoid arthritis. Matrix 1991. 11: 296-301.
35. Stetler-Stevenson, M., Mansoor, A., Lim, M., Fukushima, P., Kehrl, J., Marti, G., Ptaszynski, K., Wang, J. and Stetler-Stevenson, W. G., Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood. 1997. 89: 1708-1715.
36. Sinclair, A. J. and Farrell, P. J., Methods to study Epstein-Barr visus and p53 status in human cells. In Aldoph, K. W. (ed.) Methods in Molecular Genetics. Academic Press, Orlando. FL 1995, pp 89.
37. + B lymphocytes positively selected from buffy coats by immunomagnetic separation. Eur. J. Immunol. 1990. 20: 201-206.
38. Defrance, T., Aubry, J. P., Rousset, F., Vanbervliet, B., Bonnefoy, J. Y., Arat, N., Takebe, Y., Yokota, T., Lee, F., Arai, K., de Vries, J. E. and Banchereau, J., Human recombinant interleukin 4 induces Fcg receptors (CD23) on normal human B lymphocytes. J. Exp. Med. 1987. 165: 1459-1467.
39. Chomczynski, P. and Sacchi, N., Single step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 1987. 162: 156-159.
40. Sambrook, J., Fritsch, E. F. and Maniatis, T. (Eds.) Molecular cloning: a laboratory manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
41. Stetler-Stevenson, W. G., Brown, P. D., Onisto, M., Levy, A. T. and Liotta, L. A., Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem. 1990. 265: 13933-13938.